Healthcare investment firm Vivo Capital has closed an RMB-denominated fund at almost 10 billion yuan ($1.4 billion) to leverage global resources and fuel the growth of its Chinese portfolio.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
